Neurology · Gordon Holmes Syndrome

The Path to a Diagnosis

At a Glance

Gordon Holmes syndrome is diagnosed by combining clinical evidence of cerebellar ataxia with low sex hormones and low or inappropriately normal LH and FSH. Brain MRI and genetic testing can support the diagnosis, while treatable look-alike conditions must also be considered.

Confirming a diagnosis of Gordon Holmes Syndrome (GHS) is a meticulous process of “connecting the dots” between two seemingly unrelated body systems: the brain’s control center for balance and its control center for reproduction ^[1].

Because the symptoms of GHS overlap with many other conditions, doctors use several components to reach a diagnosis, recognizing that a universal diagnostic algorithm does not exist.

1. The Endocrine Evaluation (Hormones)

The first step is evaluating for hypogonadotropic hypogonadism. This means the brain is not sending the signals (hormones) needed for the reproductive organs to function, though those organs still need individual assessment ^[2].

The Blood Test: Doctors look for a pattern of low sex steroids (testosterone in males, estrogen/estradiol in females) combined with low or “inappropriately normal” levels of LH (luteinizing hormone) and FSH (follicle-stimulating hormone) ^[3]^[4].
The Nuance: Early-morning repeat testing is particularly relevant to testosterone assessment. Evaluation may also include medication and toxin review, nutritional assessment, thyroid function, prolactin, and other pituitary testing depending on your symptoms, as obesity or illness can affect interpretation ^[5]^[6].

2. Neurological Imaging (The Brain MRI)

A brain MRI may be used to look for structural changes, but findings are variable, supportive, and not definitive.

Cerebellar Atrophy: A common finding where the cerebellum appears smaller than expected ^[7]^[8].
White Matter Lesions: In certain subtypes, particularly RNF216, the MRI may show bright spots or “lesions” in the white matter ^[7]^[9].
Pituitary Imaging: Pituitary imaging is used to assess other causes of hypogonadism rather than to strictly confirm GHS ^[10]^[11].

3. Molecular Testing

Genetic testing can support a molecular diagnosis, but it is available only for some patients ^[1].

Comprehensive Testing: Standard tests may miss some mutations. Doctors often use targeted panels, Whole Exome Sequencing (WES), or Whole Genome Sequencing (WGS) ^[12]^[13]. A negative genetic test or an unresolved gene does not necessarily exclude a clinically suspected syndrome.

Ruling Out the “Look-Alikes”

Before attributing the presentation to GHS, your care team considers acquired, treatable causes of ataxia and hormone issues.

Condition	Why it looks like GHS	How it is considered
Gluten Ataxia	Causes balance issues and cerebellar damage ^[14].	A specialist diagnosis. Patients should not start a restrictive gluten-free diet solely on the basis of an unvalidated antibody result ^[15].
Vitamin E Deficiency	A lack of Vitamin E can mimic genetic ataxia symptoms ^[16].	Simple blood test for Vitamin E levels ^[17].
Wilson Disease	A copper-processing disorder causing movement and liver issues ^[16].	Testing copper levels in the blood and a 24-hour urine collection when clinically indicated ^[18].
Anti-GAD Ataxia	An autoimmune condition where the body attacks the cerebellum ^[19].	Testing for GAD antibodies directed by a specialist ^[20].
4H/POLR3 Syndrome	Causes hypogonadism and ataxia, but also affects teeth and myelin ^[21].	MRI patterns and checking for dental abnormalities ^[22]^[23].

Components Often Considered in Diagnosis

Clinicians may use these components, but a rigid checklist is not required, as the phenotype can evolve over time:

Clinical Ataxia: Confirmed balance and coordination issues on a neurological exam ^[1].
Central Hypogonadism: Low sex steroids with low or inappropriately normal gonadotropins ^[2].
Supportive MRI: Evidence of cerebellar shrinkage or white matter changes ^[7].
Genetic Identification: A pathogenic variant in a known GHS-associated gene ^[12].

Common questions in this guide

How is Gordon Holmes syndrome diagnosed?

There is no single test or universal checklist. Clinicians combine a neurological examination showing balance and coordination problems, blood tests showing low sex hormones with low or inappropriately normal LH and FSH, supportive MRI findings, and genetic testing when available.

What does hypogonadotropic hypogonadism mean?

Hypogonadotropic hypogonadism means the brain is not sending enough hormone signals to the reproductive organs. Blood tests typically show low sex steroids with low or inappropriately normal LH and FSH, and the reproductive organs may still need separate evaluation.

Can a brain MRI confirm Gordon Holmes syndrome?

No. MRI findings are variable and supportive rather than definitive; they may include cerebellar atrophy or, in some RNF216-related cases, white-matter lesions. Pituitary imaging is mainly used to look for other causes of hormone deficiency.

What genetic testing is used for Gordon Holmes syndrome?

Testing may include a targeted gene panel or broader tests called whole-exome sequencing and whole-genome sequencing. Depending on the test, clinicians may also need to look for larger DNA changes such as copy-number variants, because standard testing can miss some mutations.

Can a negative genetic test rule out Gordon Holmes syndrome?

No. Genetic testing is available only for some patients, and a test may miss a mutation or fail to identify the responsible gene. Doctors may still consider the syndrome when the pattern of ataxia and brain-related hormone deficiency fits.

What other conditions should be ruled out before diagnosing Gordon Holmes syndrome?

Clinicians may evaluate treatable or potentially treatable look-alikes, including gluten ataxia, vitamin E deficiency, Wilson disease, anti-GAD autoimmune ataxia, and 4H/POLR3 syndrome. Testing may include blood or urine tests, specialist assessment, MRI review, and dental evaluation. An unvalidated antibody result alone should not be the sole reason to start a restrictive gluten-free diet.

Why might my doctor recommend eye or dental exams during the workup?

Vision or dental findings can point toward other syndromes that resemble Gordon Holmes syndrome, such as Boucher-Neuhäuser or 4H syndrome. These examinations do not by themselves confirm GHS, but they can help guide the differential diagnosis.

Get notified when new evidence is published on Cerebellar ataxia-hypogonadism syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (23)

1
Ataxia and Hypogonadism: a Review of the Associated Genes and Syndromes.
De Michele G, Maione L, Cocozza S, et al.
Cerebellum (London, England) 2024; (23(2)):688-701 doi:10.1007/s12311-023-01549-x.
PMID: 36997834
2
Etiologies and clinical characteristics of primary amenorrhea: A study from a quaternary care hospital in southern Thailand.
Peeyananjarassri K, Klangsin S, Bhumsiriwilai P, et al.
The journal of obstetrics and gynaecology research 2025; (51(7)):e70009 doi:10.1111/jog.70009.
PMID: 40685931
3
Gonadal recovery in men with prolactinomas on cabergoline: 6-month testosterone levels as a predictor of testosterone replacement timing.
Fedai NK, Uzun N, Bostan H, et al.
Hormones (Athens, Greece) 2026; doi:10.1007/s42000-026-00766-3.
PMID: 41926073
4
Hypogonadotropic Hypogonadism.
Bangalore Krishna K, Fuqua JS, Witchel SF
Endocrinology and metabolism clinics of North America 2024; (53(2)):279-292 doi:10.1016/j.ecl.2024.01.008.
PMID: 38677870
5
Diagnosis of Male Central Hypogonadism During Childhood.
Grinspon RP, Castro S, Brunello FG, et al.
Journal of the Endocrine Society 2021; (5(11)):bvab145 doi:10.1210/jendso/bvab145.
PMID: 34589657
6
Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy.
Yeap BB, Grossmann M, McLachlan RI, et al.
The Medical journal of Australia 2016; (205(4)):173-8 doi:10.5694/mja16.00393.
PMID: 27510348
7
Clinical and genetic spectrum of RNF216-related disorder: a new case and literature review.
Wu C, Zhang Z
Journal of medical genetics 2024; (61(5)):430-434 doi:10.1136/jmg-2023-109397.
PMID: 38050071
8
Multifaceted and Age-Dependent Phenotypes Associated With Biallelic PNPLA6 Gene Variants: Eight Novel Cases and Review of the Literature.
Nanetti L, Di Bella D, Magri S, et al.
Frontiers in neurology 2021; (12()):793547 doi:10.3389/fneur.2021.793547.
PMID: 35069422
9
A novel mutation in RNF216 gene in a Turkish case with Gordon Holmes syndrome.
Durmaz Çelik N, Erzurumluoğlu E, Özben S, et al.
BMC medical genomics 2023; (16(1)):98 doi:10.1186/s12920-023-01529-4.
PMID: 37161390
10
Hypogonadotropic Hypogonadism as First Presentation of the Severe Neuroendocrine Disorder Caused by RNF216.
Rochtus A, Asscherickx W, Timmers M, et al.
JCEM case reports 2024; (2(11)):luae195 doi:10.1210/jcemcr/luae195.
PMID: 39444518
11
Novel PNPLA6 Variants: Hypogonadotropic Hypogonadism, Pituitary Hypoplasia, Anosmia, and Cerebellar Atrophy in Siblings.
Hussain MA, Kumar V, Chapla A, et al.
JCEM case reports 2026; (4(1)):luaf286 doi:10.1210/jcemcr/luaf286.
PMID: 41356532
12
Identification of a large homozygous RNF216 deletion in a Chinese patient with gordon holmes syndrome.
Wu B, Duan R, Pi Z, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(8)):4001-4006 doi:10.1007/s10072-025-08169-9.
PMID: 40237971
13
Ataxia and Hypogonadotropic Hypogonadism with Intrafamilial Variability Caused by RNF216 Mutation.
Alqwaifly M, Bohlega S
Neurology international 2016; (8(2)):6444 doi:10.4081/ni.2016.6444.
PMID: 27441066
14
[Cerebellar Ataxia and Autoantibodies].
Nanri K, Yoshikura N, Kimura A, et al.
Brain and nerve = Shinkei kenkyu no shinpo 2018; (70(4)):371-382 doi:10.11477/mf.1416201010.
PMID: 29632285
15
Guidelines for treatment of immune-mediated cerebellar ataxias.
Mitoma H, Hadjivassiliou M, Honnorat J
Cerebellum & ataxias 2015; (2()):14 doi:10.1186/s40673-015-0034-y.
PMID: 26561527
16
Ataxias: Hereditary, Acquired, and Reversible Etiologies.
Lin CR, Kuo SH
Seminars in neurology 2023; (43(1)):48-64 doi:10.1055/s-0043-1763511.
PMID: 36828010
17
Ataxia.
Kuo SH
Continuum (Minneapolis, Minn.) 2019; (25(4)):1036-1054 doi:10.1212/CON.0000000000000753.
PMID: 31356292
18
Degenerative and acquired sporadic adult onset ataxia.
Lieto M, Roca A, Santorelli FM, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2019; (40(7)):1335-1342 doi:10.1007/s10072-019-03856-w.
PMID: 30927137
19
Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.
Baizabal-Carvallo JF, Alonso-Juarez M
Journal of neural transmission (Vienna, Austria : 1996) 2017; (124(10)):1171-1182 doi:10.1007/s00702-017-1754-3.
PMID: 28689294
20
GAD65 neurological autoimmunity.
McKeon A, Tracy JA
Muscle & nerve 2017; (56(1)):15-27 doi:10.1002/mus.25565.
PMID: 28063151
21
4H Leukodystrophy: Lessons from 3T Imaging.
Cayami FK, Bugiani M, Pouwels PJW, et al.
Neuropediatrics 2018; (49(2)):112-117 doi:10.1055/s-0037-1608780.
PMID: 29179231
22
Recessive Mutations in POLR3B Encoding RNA Polymerase III Subunit Causing Diffuse Hypomyelination in Patients with 4H Leukodystrophy with Polymicrogyria and Cataracts.
Jurkiewicz E, Dunin-Wąsowicz D, Gieruszczak-Białek D, et al.
Clinical neuroradiology 2017; (27(2)):213-220 doi:10.1007/s00062-015-0472-1.
PMID: 26478204
23
Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia.
Minnerop M, Kurzwelly D, Wagner H, et al.
Brain : a journal of neurology 2017; (140(6)):1561-1578 doi:10.1093/brain/awx095.
PMID: 28459997

This page is for informational purposes only and does not constitute medical advice about suspected Gordon Holmes syndrome. Your neurologist, endocrinologist, and genetics team should interpret your hormone tests, MRI, and genetic results.